Diapride M2 HV 2mg/500mg/0.3mg Tablet SR
By Diapride MV
Rx
15 Tablet SR in a Strip

Composition
Glimepiride(2mg) + Metformin(500mg) + Voglibose(0.3mg)

Manufacturer - Micro Labs Ltd
27, RACE COURSE ROAD, BANGALORE-560 001, INDIA

Expires on or after
July, 2025

liver
When using Diapride M2 HV 2mg/500mg/0.3mg Tablet SR, it is important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment when taking this medication, so it's crucial to consult your doctor before starting treatment. Typically, Diapride M2 HV 2mg/500mg/0.3mg Tablet SR is initiated at a low dose for individuals with mild to moderate liver disease. However, it is not advised for use in patients with severe liver disease. Be sure to seek guidance from your healthcare provider to ensure the safe and appropriate use of Diapride M2 HV 2mg/500mg/0.3mg Tablet SR.

kidney
Diapride M2 HV 2mg/500mg/0.3mg Tablet SR may not be safe for patients with kidney disease. It is advised to avoid using this medication if you have kidney issues. Please consult your doctor before taking Provog GM Tablet SR, especially if you have severe kidney disease.

alcohol
It is not safe to drink alcohol while taking Diapride M2 HV 2mg/500mg/0.3mg Tablet SR.

driving
It is important to note that your driving ability may be impacted if you experience low or high blood sugar levels while taking Diapride M2 HV 2mg/500mg/0.3mg Tablet SR. It is advisable to avoid driving in such situations.

pregnancy
Diapride M2 HV 2mg/500mg/0.3mg Tablet SR may not be safe to use during pregnancy. Animal studies indicate potential harm to the baby's development. Your doctor will assess the risks versus benefits before prescribing. Consulting your doctor is advised.

breastfeeding
Diapride M2 HV 2mg/500mg/0.3mg Tablet SR is likely unsafe during breastfeeding as it may pass into breastmilk and harm the baby based on limited data.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹202
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024